Rare Incidence of Congestive Heart Failure in Gastrointestinal Stromal Tumor and Other Sarcoma Patients Receiving Imatinib Mesylate (IM)

BACKGROUND: We sought to determine the incidence and severity of cardiovascular toxicity due to imatinib mesylate(IM) in GIST and other sarcoma patients, and to explore cardiotoxicity due to IM using cell culture and in vitro models. METHODS: To determine the incidence and significance of serious ca...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cancer
Main Authors: Trent, Jonathan C., Patel, Shalin S., Zhang, Jianhu, Araujo, Dejka M., Plana, Juan-Carlos, Lenihan, Daniel J., Fan, Dominic, Patel, Shreyaskumar R., Benjamin, Robert S., Khakoo, Aarif Y.
Formato: Artigo
Idioma:Inglês
Publicado em: 2010
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4306337/
https://ncbi.nlm.nih.gov/pubmed/19885836
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cncr.24683
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados